ÂÜÀòÂÒÂ×

John Robblee is a seasoned professional with extensive experience in the biopharmaceutical industry, currently serving as Senior Vice President of CMC at hC Bioscience, Inc. since February 2024, where leadership in Tech Ops, Analytical, and Process Development is a primary focus. Prior roles include Vice President positions at Intergalactic Therapeutics and Carmine Therapeutics, as well as Director of Analytical Development at Codiak BioSciences and Generation Bio, where John successfully built analytical teams and advanced drug characterization efforts. Notable experience at Momenta Pharmaceuticals includes contributions as Associate Director in multiple roles, shaping regulatory strategies for biosimilar programs, facilitating FDA interactions, and leading research initiatives that achieved significant cost savings and streamlined approval processes. Academic credentials feature a Ph.D. in Biophysical Chemistry from the University of California, Berkeley, complemented by a B.A. in Chemistry from Haverford College.